Aquestive Therapeutics Eulerpool naujienos

Aquestive Therapeutics Eulerpool News

Aquestive Therapeutics akcijų naujienos

Aquestive Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Aquestive Therapeutics naujienas mes pateikiame čia.

• spalio 25 d. ·

  Yahoo
  Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study
• spalio 25 d. ·

  Yahoo
  Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting
• spalio 25 d. ·

  TipRanks
  Aquestive Therapeutics’ Favorable OAS Study Boosts Anaphylm’s Prospects with Raised Price Target and Buy Rating
• spalio 25 d. ·

  TipRanks
  Aquestive to present subsequent analysis of data from Anaphylm study
• spalio 25 d. ·

  TipRanks
  Piper Sandler Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)
• spalio 25 d. ·

  TipRanks
  Strong Buy Rating for Aquestive Therapeutics’ Anaphylm™ Driven by Promising Study Results and Market Potential
• spalio 24 d. ·

  Yahoo
  Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film
• spalio 24 d. ·

  TipRanks
  Aquestive Therapeutics’ Anaphylm: Rapid and Reliable Allergy Treatment Gains ‘Buy’ Rating
• spalio 24 d. ·

  TipRanks
  Lake Street Remains a Buy on Aquestive Therapeutics (AQST)
• spalio 24 d. ·

  TipRanks
  Aquestive announces primary, secondary endpoints met in OAS challenge study